HRSA Sends White House Guidance To Cement Stance On 340B Rebate Models

By Gabrielle Wanneh / June 11, 2025 at 5:34 PM

The Health Resources and Services Administration has sent a guidance document to the White House budget office that likely reveals its formal stance on the hot-button issue of whether drug makers can use a new rebate model to rein in 340B discounts -- coming as HRSA is poised to also tell a district court and stakeholders how it will proceed on the issue.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.